1. Keeley, EC, Boura, JA, Grines, CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003; 361: 13–20.
Google Scholar | Crossref | Medline | ISI2. Bax, M, de Winter, RJ, Koch, KT, et al. Time course of microvascular resistance of the infarct and noninfarct coronary artery following an anterior wall acute myocardial infarction. Am J Cardiol 2006; 97: 1131–1136.
Google Scholar | Crossref | Medline3. Schafer, U, Kurz, T, Jain, D, et al. Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: role of neurohumoral activation? Basic Res Cardiol 2002; 97: 399–408.
Google Scholar | Crossref | Medline4. De Bruyne, B, Baudhuin, T, Melin, JA, et al. Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation 1994; 89: 1013–1022.
Google Scholar | Crossref | Medline5. Johnson, NP, Gould, KL. Physiological basis for angina and ST-segment change PET-verified thresholds of quantitative stress myocardial perfusion and coronary flow reserve. JACC Cardiovasc Imaging 2011; 4: 990–998.
Google Scholar | Crossref | Medline6. Joye, JD, Schulman, DS, Lasorda, D, et al. Intracoronary Doppler guide wire versus stress single-photon emission computed tomographic thallium-201 imaging in assessment of intermediate coronary stenoses. J Am Coll Cardiol 1994; 24: 940–947.
Google Scholar | Crossref | Medline | ISI7. Johnson, NP, Gould, KL. Integrating noninvasive absolute flow, coronary flow reserve, and ischemic thresholds into a comprehensive map of physiological severity. JACC Cardiovasc Imaging 2012; 5: 430–440.
Google Scholar | Crossref | Medline8. Gould, KL, Johnson, NP, Roby, AE, et al. Regional, Artery-specific thresholds of quantitative myocardial perfusion by PET associated with reduced myocardial infarction and death after revascularization in stable coronary artery disease. J Nucl Med 2019; 60: 410–417.
Google Scholar | Crossref | Medline9. Van de Hoef, TP, Echavarria-Pinto, M, van Lavieren, MA, et al. Diagnostic and prognostic implications of coronary flow capacity: A comprehensive cross-modality physiological concept in ischemic heart disease. JACC Cardiovasc Inter 2015; 8: 1670–1680.
Google Scholar | Crossref | Medline10. Stegehuis, VE, Wijntjens, GWM, Bax, M, et al. Impact of clinical and hemodynamic factors on coronary flow reserve and invasive coronary flow capacity in non-obstructed coronary arteries – a patient level pooled analysis of the DEBATE and ILIAS studies. Eurointervention. Epub ahead of print 18 January 2020. DOI: 10.4244/eij-d-19-00774.
Google Scholar11. Van de Hoef, TP, Bax, M, Meuwissen, M, et al. Impact of coronary microvascular function on long-term cardiac mortality in patients with acute ST-segment-elevation myocardial infarction. Circ Cardiovasc Intervs 2013; 6: 207–215.
Google Scholar | Crossref | Medline12. Kern, MJ, Bach, RG, Mechem, CJ, et al. Variations in normal coronary vasodilatory reserve stratified by artery, gender, heart transplantation and coronary artery disease. J Am Coll Cardiol 1996; 28: 1154–1160.
Google Scholar | Crossref | Medline | ISI13. Meuwissen, M. Role of fractional and coronary flow reserve in clinical decision making in intermediate coronary lesions. Interv Cardiol 2009; 1: 237–255.
Google Scholar | Crossref14. De Bruyne, B. FAME II: FFR pinpoints stable CAD patients who fare worse with OMT. http://www.theheart.org/article/1398627.do (2012, accessed 18 May 2018).
Google Scholar15. Guzzetti, S, Spyrou, N, Rosen, SD, et al. Low frequency spectral component of heart rate variability and myocardial beta-adrenoceptor density after acute myocardial infarction. Basic Res Cardiol 2002; 97: 97–104.
Google Scholar | Crossref | Medline16. Heusch, G. Adenosine and maximum coronary vasodilation in humans: Myth and misconceptions in the assessment of coronary reserve. Basic Res Cardiol 2010; 105: 1–5.
Google Scholar | Crossref | Medline17. Dibra, A, Mehilli, J, Dirschinger, J, et al. Thrombolysis in myocardial infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis. J Am Coll Cardiol 2003; 41: 925–929.
Google Scholar | Crossref | Medline18. Tarantini, G, Cacciavillani, L, Corbetti, F, et al. Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: A study performed with contrast-enhanced magnetic resonance. J Am Coll Cardiol 2005; 46: 1229–1235.
Google Scholar | Crossref | Medline | ISI19. Rezkalla, SH, Kloner, RA. Coronary no-reflow phenomenon. Curr Treat Options Cardiovasc Med 2005; 7: 75–80.
Google Scholar | Crossref | Medline20. Alexanderson, E, Jacome, R, Jimenez-Santos, M, et al. Evaluation of the endothelial function in hypertensive patients with 13N-ammonia PET. J Nucl Cardiol 2012; 19: 979–986.
Google Scholar | Crossref | Medline21. Fearon, WF, Low, AF, Yong, AS, et al. Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention. Circulation 2013; 127: 2436–2441.
Google Scholar | Crossref | Medline | ISI22. Furber, AP, Prunier, F, Nguyen, HC, et al. Coronary blood flow assessment after successful angioplasty for acute myocardial infarction predicts the risk of long-term cardiac events. Circulation 2004; 110: 3527–3533.
Google Scholar | Crossref | Medline23. Takahashi, T, Hiasa, Y, Ohara, Y, et al. Usefulness of coronary flow reserve immediately after primary coronary angioplasty for acute myocardial infarction in predicting long-term adverse cardiac events. Am J Cardiol 2007; 100: 806–811.
Google Scholar | Crossref | Medline24. Kitabata, H, Kubo, T, Ishibashi, K, et al. Prognostic value of microvascular resistance index immediately after primary percutaneous coronary intervention on left ventricular remodeling in patients with reperfused anterior acute ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2013; 6: 1046–1054.
Google Scholar | Crossref | Medline25. Bax, M, de Winter, RJ, Schotborgh, CE, et al. Short- and long-term recovery of left ventricular function predicted at the time of primary percutaneous coronary intervention in anterior myocardial infarction. J Am Coll Cardiol 2004; 43: 534–541.
Google Scholar | Crossref | Medline26. Mehta, SR, Wood, DA, Storey, RF, et al. Complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med 2019; 381: 1411–1421.
Google Scholar | Crossref | Medline27. Iannaccone, M, Souteyrand, G, Niccoli, G, et al. Clinical impact of optical coherence tomography findings on culprit plaque in acute coronary syndrome: The OCT-FORMIDABLE study registry. Catheter Cardiovasc Interv 2018; 92: E486–E492.
Google Scholar | Crossref | Medline28. Kajander, OA, Pinilla-Echeverri, N, Jolly, SS, et al. Culprit plaque morphology in STEMI – an optical coherence tomography study: Insights from the TOTAL-OCT substudy. Eurointervention 2016; 12: 716–723.
Google Scholar | Crossref | Medline29. Pinilla-Echeverri, N. Non-culprit lesion plaque morphology in patients with ST-segment elevation myocardial infarction: Results from the COMPLETE trial optical coherence tomography (OCT) substudy. Presented at The American Heart Association (AHA) 2019, Philadelphia, PA, USA, 17 November 2019.
Google Scholar30. Smits, PC, Abdel-Wahab, M, Neumann, FJ, et al. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N Engl J Med 2017; 376: 1234–1244.
Google Scholar | Crossref | Medline31. Engstrom, T, Kelbaek, H, Helqvist, S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): An open-label, randomised controlled trial. Lancet 2015; 386: 665–671.
Google Scholar | Crossref | Medline32. Thim, T, Gotberg, M, Frobert, O, et al. Nonculprit stenosis evaluation using instantaneous wave-free ratio in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2017; 10: 2528–2535.
Google Scholar | Crossref | Medline33. Mejia-Renteria, H, Lee, JM, van der Hoeven, NW, et al. Coronary microcirculation downstream non-infarct-related arteries in the subacute phase of myocardial infarction: Implications for physiology-guided revascularization. J Am Heart Assoc 2019; 8: e011534.
Google Scholar | Crossref | Medline34. Cuculi, F, de Maria, GL, Meier, P, et al. Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after ST-segment elevation myocardial infarction. J Am Coll Cardiol 2014; 64: 1894–1904.
Google Scholar | Crossref | Medline35. Wijntjens, GWM, van Uffelen, EL, Echavarria-Pinto, M, et al. Individual lesion-level meta-analysis comparing various doses of intracoronary bolus injection of adenosine with intravenous administration of adenosine for fractional flow reserve assessment. Circ Cardiovasc Interv 2020; 13: e007893.
Google Scholar | Crossref | Medline36. Gould, KL, Lipscomb, K, Calvert, C. Compensatory changes of the distal coronary vascular bed during progressive coronary constriction. Circulation 1975; 51: 1085–1094.
Google Scholar | Crossref | Medline